Cannabis extract triggered cancer cell death in 3D pancreatic tumor models

CBD emerged as the primary compound responsible for inducing apoptosis in pancreatic cancer cells. While gemcitabine (standard treatment) only triggered cell cycle arrest in G0/G1, CBD also activated the full cell death signaling cascade, including accumulation of intracellular superoxide ions, mitochondrial membrane disruption, G1 cell cycle arrest, and ultimately apoptosis.

In vitro study using 3D cancer models of human pancreatic tumor cells. Compared three extraction methods for cannabinoid yield and anticancer activity. Tested cannabis extracts against pure CBD and gemcitabine, measuring IC50 values, cell cycle, apoptosis pathways, and oxidative stress.

Pancreatic cancer has one of the lowest survival rates of any cancer. Finding that CBD triggers more complete cell death pathways than the standard drug gemcitabine highlights its potential as a complementary approach.

The use of 3D tumor models, which better mimic real tumors than flat cell cultures, strengthens the relevance of these findings, though significant gaps remain before clinical application.

In vitro study, even with 3D models. Concentrations of CBD used may not be achievable in the human pancreas. No animal or human studies conducted. Single cancer cell line tested.